Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Deloitte
Covington
Teva
Fuji
Fish and Richardson
Citi
McKinsey
US Army

Generated: December 16, 2018

DrugPatentWatch Database Preview

HERCEPTIN Drug Profile

« Back to Dashboard

Summary for Tradename: HERCEPTIN
Pharmacology for HERCEPTIN
Mechanism of ActionHER2/Neu/cerbB2 Antagonists

US Patents for HERCEPTIN

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Bayer Intellectual Property GMBH (Monheim, DE) ➤ Sign Up RX Orphan search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up 3-V Biosciences, Inc. (Menlo Park, CA) ➤ Sign Up RX Orphan search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up LegoChem Biosciences, Inc. (Daejeon, KR) ➤ Sign Up RX Orphan search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Bioasis Technologies, Inc. (Guilford, CT) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for HERCEPTIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013028 Lithuania ➤ Sign Up PRODUCT NAME: TRASTUZUMABUM EMTANSINUM; REGISTRATION NO/DATE: EU/1/13/885 20131115
336 Luxembourg ➤ Sign Up PRODUCT NAME: TRASTUZUMAB EMTANSINE ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES KADCYLA
2013 00063 Denmark ➤ Sign Up PRODUCT NAME: TRASTUZUMABEMTANSIN; REG. NO/DATE: EU/1/13/885 20131115
2015000061 Germany ➤ Sign Up PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
US Army
Deloitte
Johnson and Johnson
Daiichi Sankyo
UBS
Express Scripts
Baxter
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.